RalB regulates contractility-driven cancer dissemination upon TGFβ stimulation via the RhoGEF GEF-H1

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Biondini, Marco ^a,b   Duclos, Guillaume ^a,c   Meyer Schaller, Nathalie ^d   Silberzan, Pascal ^a,c   Camonis, Jacques ^a,b   Carla Parrini, Maria ^a,b  

^a INSTITUT CURIE   (France)

^b INSERM   (France)

^c CNRS   (France)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; AMIDE; ARHGEF2 PROTEIN, HUMAN; PYRIDINE DERIVATIVE; RAC1 PROTEIN; RAC1 PROTEIN, HUMAN; RAL PROTEIN; RALA PROTEIN, HUMAN; RALB PROTEIN, HUMAN; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR; RHO KINASE; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ANTAGONISTS AND INHIBITORS; ATOMIC FORCE MICROSCOPY; DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; GENETICS; HUMAN; METABOLISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AMIDES; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MICROSCOPY, ATOMIC FORCE; PYRIDINES; RAC1 GTP-BINDING PROTEIN; RAL GTP-BINDING PROTEINS; RHO GUANINE NUCLEOTIDE EXCHANGE FACTORS; RHO-ASSOCIATED KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84936972912     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11759     Document Type: Article

References (51)

1. Bodemann, B. O. & White, M. A. Ral GTPases and cancer: linchpin support of the tumorigenic platform. Nat. Rev. Cancer 8, 133-140 (2008).
2. Gentry, L. R., Martin, T. D., Reiner, D. J. & Der, C. J. Ral small GTPase signaling and oncogenesis: More than just 15 minutes of fame. Biochim. Biophys. Acta BBA - Mol. Cell Res. 1843, 2976-2988 (2014).
3. Hamad, N. M. et al. Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev. 16, 2045-2057 (2002).
4. Chien, Y. & White, M. A. RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep. 4, 800-806 (2003).
5. Oxford, G. et al. RalA and RalB: antagonistic relatives in cancer cell migration. Cancer Res. 65, 7111-7120 (2005).
6. Rossé, C. et al. RalB mobilizes the exocyst to drive cell migration. Mol. Cell. Biol. 26, 727-734 (2006).
7. Lim, K.-H. et al. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. Curr. Biol. CB 16, 2385-2394 (2006).
8. Rybko, V. A. et al. Different metastasis promotive potency of small G-proteins RalA and RalB in in vivo hamster tumor model. Cancer Cell Int. 11, 22 (2011).
9. He, B. & Guo, W. The exocyst complex in polarized exocytosis. Curr. Opin. Cell Biol. 21, 537-542 (2009).
10. Parrini, M. C. et al. SH3BP1, an exocyst-associated RhoGAP, inactivates Rac1 at the front to drive cell motility. Mol. Cell 42, 650-661 (2011).
11. Friedl, P. & Alexander, S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147, 992-1009 (2011).
12. Charras, G. & Sahai, E. Physical influences of the extracellular environment on cell migration. Nat. Rev. Mol. Cell Biol. 15, 813-824 (2014).
13. Wolf, K. & Friedl, P. Extracellular matrix determinants of proteolytic and non-proteolytic cell migration. Trends Cell Biol. 21, 736-744 (2011).
14. Massagué, J. TGFbeta in Cancer. Cell 134, 215-230 (2008).
15. Pickup, M., Novitskiy, S. & Moses, H. L. The roles of TGFβ in the tumour microenvironment. Nat. Rev. Cancer 13, 788-799 (2013).
16. Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178-196 (2014).
17. Tsai, J. H. & Yang, J. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 27, 2192-2206 (2013).
18. Kasai, H., Allen, J. T., Mason, R. M., Kamimura, T. & Zhang, Z. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir. Res. 6, 56 (2005).
19. Tang, Y., Shu, G., Yuan, X., Jing, N. & Song, J. FOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelialto- mesenchymal transition in human lung cancers. Cell Res. 21, 316-326 (2011).
20. Yu, X. & Machesky, L. M. Cells assemble invadopodia-like structures and invade into matrigel in a matrix metalloprotease dependent manner in the circular invasion assay. PloS One 7, e30605 (2012).
21. Weigelin, B., Bakker, G.-J. & Friedl, P. Intravital third harmonic generation microscopy of collective melanoma cell invasion. IntraVital 1, 32-43 (2012).
22. Eckert, M. A. et al. Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell 19, 372-386 (2011).
23. Saito, R.-A. et al. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells. Cancer Res. 69, 2783-2791 (2009).
24. Butler, J. P., Tolić-Nørrelykke, I. M., Fabry, B. & Fredberg, J. J. Traction fields, moments, and strain energy that cells exert on their surroundings. Am. J. Physiol. Cell Physiol. 282, C595-605 (2002).
25. Olson, M. F. & Sahai, E. The actin cytoskeleton in cancer cell motility. Clin. Exp. Metastasis 26, 273-287 (2009).
26. Pathak, R. et al. The microtubule-associated Rho activating factor GEF-H1 interacts with exocyst complex to regulate vesicle traffic. Dev. Cell 23, 397-411 (2012).
27. Birkenfeld, J. et al. GEF-H1 modulates localized RhoA activation during cytokinesis under the control of mitotic kinases. Dev. Cell 12, 699-712 (2007).
28. Guilluy, C. et al. The Rho GEFs LARG and GEF-H1 regulate the mechanical response to force on integrins. Nat. Cell Biol. 13, 722-727 (2011).
29. Heck, J. N. et al. Microtubules regulate GEF-H1 in response to extracellular matrix stiffness. Mol. Biol. Cell 23, 2583-2592 (2012).
30. Tsapara, A. et al. The RhoA Activator GEF-H1/Lfc Is a Transforming Growth Factor-β Target Gene and Effector That Regulates α -Smooth Muscle Actin Expression and Cell Migration. Mol. Biol. Cell 21, 860-870 (2010).
31. Liao, Y. C. et al. Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling. Oncogene 31, 3086-3097 (2012).
32. Ridgway, L. D., Wetzel, M. D., Ngo, J. A., Erdreich-Epstein, A. & Marchetti, D. Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells. Mol. Cancer Res. MCR 10, 689-702 (2012).
33. Von Thun, A. et al. Extracellular signal-regulated kinase regulates RhoA activation and tumor cell plasticity by inhibiting guanine exchange factor H1 activity. Mol. Cell. Biol. 33, 4526-4537 (2013).
34. Cheng, I. K. C. et al. GEF-H1 over-expression in hepatocellular carcinoma promotes cell motility via activation of RhoA signalling. J. Pathol. 228, 575-585 (2012).
35. Nalbant, P., Chang, Y.-C., Birkenfeld, J., Chang, Z.-F. & Bokoch, G. M. Guanine nucleotide exchange factor-H1 regulates cell migration via localized activation of RhoA at the leading edge. Mol. Biol. Cell 20, 4070-4082 (2009).
36. Eitaki, M., Yamamori, T., Meike, S., Yasui, H. & Inanami, O. Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells. BMC Cancer 12, 469 (2012).
37. Vega, F. M., Fruhwirth, G., Ng, T. & Ridley, A. J. RhoA and RhoC have distinct roles in migration and invasion by acting through different targets. J. Cell Biol. 193, 655-665 (2011).
38. Sanz-Moreno, V. et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell 135, 510-523 (2008).
39. Wyckoff, J. B., Pinner, S. E., Gschmeissner, S., Condeelis, J. S. & Sahai, E. ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr. Biol. CB 16, 1515-1523 (2006).
40. Alexander, S., Weigelin, B., Winkler, F. & Friedl, P. Preclinical intravital microscopy of the tumour-stroma interface: invasion, metastasis, and therapy response. Curr. Opin. Cell Biol. 25, 659-671 (2013).
41. Kessenbrock, K., Plaks, V. & Werb, Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67 (2010).
42. Ren, Y., Li, R., Zheng, Y. & Busch, H. Cloning and characterization of GEF-H1, a microtubule-associated guanine nucleotide exchange factor for Rac and Rho GTPases. J. Biol. Chem. 273, 34954-34960 (1998).
43. Bellovin, D. I. et al. Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma. Oncogene 25, 6959-6967 (2006).
44. Coussens, L. M., Fingleton, B. & Matrisian, L. M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387-2392 (2002).
45. Fingleton, B. MMPs as therapeutic targets-still a viable option? Semin. Cell Dev. Biol. 19, 61-68 (2008).
46. Osborne, L. D. et al. TGF-β regulates LARG and GEF-H1 during EMT to impact stiffening response to force and cell invasion. Mol. Biol. Cell (2014). doi:10.1091/mbc.E14-05-1015
47. Cullis, J. et al. The RhoGEF GEF-H1 is required for oncogenic RAS signaling via KSR-1. Cancer Cell 25, 181-195 (2014).
48. Yan, C. et al. Discovery and characterization of small molecules that target the GTPase Ral. Nature 515, 443-447 (2014).
49. Tse, J. R. & Engler, A. J. Preparation of hydrogel substrates with tunable mechanical properties. Curr. Protoc. Cell Biol. Editor. Board Juan Bonifacino Al Chapter 10, Unit 10.16 (2010).
50. Tseng, Q. et al. Spatial organization of the extracellular matrix regulates cell-cell junction positioning. Proc. Natl. Acad. Sci. U. S. A. 109, 1506-1511 (2012).
51. Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671-675 (2012).